The firm will use the proceeds to develop its cell-sorting technology for cell line development, genomic sample preparation, CRISPR gene editing, and antibody discovery.
Harvard Bioscience will offer Fluxion's BioFlux and IonFlux cellular analysis platforms to its North American customers.
Labcyte and the University of Helsinki's Institute for Molecular Medicine Finland have expanded their partnership to include multiple new applications.
The company believes its system, launched earlier this year, can outperform other microfluidic technologies, yielding samples with fewer white blood cells that allow better genomic analyses.
The NIH has awarded $169 million this year to support 110 new projects in the Brain Research through Advancing Innovative Neurotechnologies Initiative.
Such an atlas could enable investigators to understand how genetic variants impact disease risk, define drug toxicities, improve therapies, and advance regenerative medicine.
The funding is being awarded under the auspices of the NIH's BRAIN Initiative Cell Census Network, which aims to establish reference cell atlases of the brain.
Gyros Protein Technologies will distribute Euro Diagnostica's reporter gene cell lines in Europe and North America.
The companies will offer CDI's human induced pluripotent stem cell-derived tissue cells with Nanion's ion channel drug discovery and screening platform.
The Ann Arbor-based biotech startup will use the funding to develop its microbubble technology that allows for removal of biomolecules from biological samples.
The company also received a grant from the Maryland Innovation Initiative to help advance the device toward commercialization.
Separately, FlowJo and Cytapex Bioinformatics said they have partnered to provide bioinformatics consulting and services for flow cytometry data analysis.
The institute will work with other HCA members to build a data-coordination platform for the initiative's researchers.
Eleven new studies from the NHLBI NextGen Consortium show different uses for iPSCs to study polygenetic diseases across various systems in the human body.
Bioké will exclusively distribute Acea's xCelligence cell analyzer in Belgium, the Netherlands, and Luxembourg.
The technique provides the scientific community with a higher-resolution methodology to determine if a mouse cell line has been correctly identified in research.
The worldwide distribution agreement expands Oxford's existing product and service portfolio, streamlining workflows for current customers, the company said.
The deal covers Biolog's line of cell analysis tools including its Gen III MicroPlate test panel for bacterial species identification.
The company plans to use the funds to support the worldwide launch of its commercial platform for propagation and gene editing in cell types that are difficult to transfect.
Funded by a $600 million gift, the Biohub will support investigators at three universities as well as two initial internal projects.
Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.
Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.
In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.
Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.